TENAYA and LUCERNE

M. Khanani, Arshad; H. Guymer, Robyn; Basu, Karen; Boston, Heather; S. Heier, Jeffrey; Korobelnik, Jean‐François; Kotecha, Aachal; Lin, Hugh; G. Silverman, David; Swaminathan, Balakumar; R. Willis, Jeffrey; Hee Yoon, Young; Quezada-Ruiz, Carlos

doi:10.1016/j.xops.2021.100076

Public

TENAYA and LUCERNE

Published in Ophthalmology Science • Nov 17, 2021

Authors:

Arshad M. Khanani

Robyn H. Guymer

Karen Basu

Abstract

PurposeTo describe the design and rationale of the phase 3 TENAYA (ClinicalTrials.gov identifier, NCT03823287) and LUCERNE (ClinicalTrials.gov identifier, NCT03823300) trials that aimed to assess efficacy, safety, and durability of faricimab, the first bispecific antibody for intraocular use, which ...

Subject

Business

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!